Permanent Pacemaker Implantation
6
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Ultrasound-Guided PECS II Block for Permanent Pacemaker Implantation
Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following TAVR
A Multimodal Strategy to Screen for and Rule-Out Delayed High-Grade Conduction Disturbances After TAVR
Biomarkers of Inflammation and Fibrosis in Conduction Disorders After TAVI
Cardiac Ganglionated Plexus Ablation Before Permanent Pacemaker Implantation in Patients With Sick Sinus Syndrome
Long Term Evaluation and Management of Atrial Fibrillation in Pacemaker Patients